位置:首页 > 蛋白库 > TCHP_HUMAN
TCHP_HUMAN
ID   TCHP_HUMAN              Reviewed;         498 AA.
AC   Q9BT92; Q8NAG0;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 149.
DE   RecName: Full=Trichoplein keratin filament-binding protein;
DE            Short=Protein TCHP;
DE   AltName: Full=Mitochondrial protein with oncostatic activity;
DE            Short=Mitostatin;
DE   AltName: Full=Tumor suppressor protein;
GN   Name=TCHP {ECO:0000312|EMBL:AAH04285.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH KRT5; KRT6A; KRT8;
RP   KRT14; KRT16 AND KRT18, AND SUBCELLULAR LOCATION.
RC   TISSUE=Liver {ECO:0000269|PubMed:15731013};
RX   PubMed=15731013; DOI=10.1242/jcs.01667;
RA   Nishizawa M., Izawa I., Inoko A., Hayashi Y., Nagata K., Yokoyama T.,
RA   Usukura J., Inagaki M.;
RT   "Identification of trichoplein, a novel keratin filament-binding protein.";
RL   J. Cell Sci. 118:1081-1090(2005).
RN   [2] {ECO:0000312|EMBL:AAG12971.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Baffa R., Croce C.M., Gomella L.G., Iozzo R.V., Vecchione A.;
RT   "A novel tumor suppressor gene at 12q (TS12Q).";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000312|EMBL:BAC03960.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine {ECO:0000312|EMBL:BAC03960.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000312|EMBL:AAH04285.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin {ECO:0000312|EMBL:AAH04285.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANTS PRO-44 AND
RP   LYS-93.
RX   PubMed=18931701; DOI=10.1038/onc.2008.381;
RA   Vecchione A., Fassan M., Anesti V., Morrione A., Goldoni S.,
RA   Baldassarre G., Byrne D., D'Arca D., Palazzo J.P., Lloyd J., Scorrano L.,
RA   Gomella L.G., Iozzo R.V., Baffa R.;
RT   "MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is
RT   downregulated in human bladder and breast cancer.";
RL   Oncogene 28:257-269(2009).
RN   [7]
RP   FUNCTION, INTERACTION WITH KCTD17, MUTAGENESIS OF LYS-50 AND LYS-57,
RP   UBIQUITINATION AT LYS-50 AND LYS-57, AND UBIQUITINATION BY THE BCR(KCTD17)
RP   COMPLEX.
RX   PubMed=25270598; DOI=10.1038/ncomms6081;
RA   Kasahara K., Kawakami Y., Kiyono T., Yonemura S., Kawamura Y., Era S.,
RA   Matsuzaki F., Goshima N., Inagaki M.;
RT   "Ubiquitin-proteasome system controls ciliogenesis at the initial step of
RT   axoneme extension.";
RL   Nat. Commun. 5:5081-5081(2014).
CC   -!- FUNCTION: Tumor suppressor which has the ability to inhibit cell growth
CC       and be pro-apoptotic during cell stress. Inhibits cell growth in
CC       bladder and prostate cancer cells by a down-regulation of HSPB1 by
CC       inhibiting its phosphorylation. May act as a 'capping' or 'branching'
CC       protein for keratin filaments in the cell periphery. May regulate
CC       K8/K18 filament and desmosome organization mainly at the apical or
CC       peripheral regions of simple epithelial cells (PubMed:15731013,
CC       PubMed:18931701). Is a negative regulator of ciliogenesis
CC       (PubMed:25270598). {ECO:0000269|PubMed:15731013,
CC       ECO:0000269|PubMed:18931701, ECO:0000269|PubMed:25270598}.
CC   -!- SUBUNIT: Interacts specifically with keratin proteins including, KRT5,
CC       KRT6A, KRT8, KRT14, KRT16 and KRT18 (PubMed:15731013). Interacts with
CC       KCTD17 (PubMed:25270598). {ECO:0000269|PubMed:15731013,
CC       ECO:0000269|PubMed:25270598}.
CC   -!- INTERACTION:
CC       Q9BT92; Q8N5M1: ATPAF2; NbExp=3; IntAct=EBI-740781, EBI-1166928;
CC       Q9BT92; O75934: BCAS2; NbExp=3; IntAct=EBI-740781, EBI-1050106;
CC       Q9BT92; Q9BUH8: BEGAIN; NbExp=3; IntAct=EBI-740781, EBI-742722;
CC       Q9BT92; Q8NA61-2: CBY2; NbExp=3; IntAct=EBI-740781, EBI-11524851;
CC       Q9BT92; Q86Z20: CCDC125; NbExp=3; IntAct=EBI-740781, EBI-11977221;
CC       Q9BT92; Q8IYE1: CCDC13; NbExp=4; IntAct=EBI-740781, EBI-10961312;
CC       Q9BT92; P0C7W6: CCDC172; NbExp=7; IntAct=EBI-740781, EBI-2548868;
CC       Q9BT92; Q01850: CDR2; NbExp=8; IntAct=EBI-740781, EBI-1181367;
CC       Q9BT92; Q86X02: CDR2L; NbExp=3; IntAct=EBI-740781, EBI-11063830;
CC       Q9BT92; Q9NPF5: DMAP1; NbExp=5; IntAct=EBI-740781, EBI-399105;
CC       Q9BT92; Q8WWB3: DYDC1; NbExp=6; IntAct=EBI-740781, EBI-740680;
CC       Q9BT92; Q9NRA8: EIF4ENIF1; NbExp=3; IntAct=EBI-740781, EBI-301024;
CC       Q9BT92; Q9NYK6-3: EURL; NbExp=3; IntAct=EBI-740781, EBI-13371226;
CC       Q9BT92; Q9NP66: HMG20A; NbExp=3; IntAct=EBI-740781, EBI-740641;
CC       Q9BT92; Q96ED9-2: HOOK2; NbExp=3; IntAct=EBI-740781, EBI-10961706;
CC       Q9BT92; Q02363: ID2; NbExp=3; IntAct=EBI-740781, EBI-713450;
CC       Q9BT92; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-740781, EBI-747204;
CC       Q9BT92; Q2KHM9: KIAA0753; NbExp=4; IntAct=EBI-740781, EBI-2805604;
CC       Q9BT92; P19012: KRT15; NbExp=5; IntAct=EBI-740781, EBI-739566;
CC       Q9BT92; P08779: KRT16; NbExp=3; IntAct=EBI-740781, EBI-356410;
CC       Q9BT92; P08727: KRT19; NbExp=3; IntAct=EBI-740781, EBI-742756;
CC       Q9BT92; Q2M2I5: KRT24; NbExp=3; IntAct=EBI-740781, EBI-2952736;
CC       Q9BT92; Q14532: KRT32; NbExp=3; IntAct=EBI-740781, EBI-1044146;
CC       Q9BT92; O76011: KRT34; NbExp=3; IntAct=EBI-740781, EBI-1047093;
CC       Q9BT92; Q92764: KRT35; NbExp=3; IntAct=EBI-740781, EBI-1058674;
CC       Q9BT92; Q6A162: KRT40; NbExp=3; IntAct=EBI-740781, EBI-10171697;
CC       Q9BT92; O95678: KRT75; NbExp=3; IntAct=EBI-740781, EBI-2949715;
CC       Q9BT92; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-740781, EBI-741037;
CC       Q9BT92; Q5JXC2: MIIP; NbExp=3; IntAct=EBI-740781, EBI-2801965;
CC       Q9BT92; Q8TD10: MIPOL1; NbExp=3; IntAct=EBI-740781, EBI-2548751;
CC       Q9BT92; Q13064: MKRN3; NbExp=9; IntAct=EBI-740781, EBI-2340269;
CC       Q9BT92; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-740781, EBI-11522433;
CC       Q9BT92; Q15742: NAB2; NbExp=7; IntAct=EBI-740781, EBI-8641936;
CC       Q9BT92; Q9UHB4: NDOR1; NbExp=7; IntAct=EBI-740781, EBI-10249760;
CC       Q9BT92; Q9Y5B8: NME7; NbExp=12; IntAct=EBI-740781, EBI-744782;
CC       Q9BT92; Q7Z3B4: NUP54; NbExp=3; IntAct=EBI-740781, EBI-741048;
CC       Q9BT92; P28074: PSMB5; NbExp=3; IntAct=EBI-740781, EBI-357828;
CC       Q9BT92; Q9UJ41-4: RABGEF1; NbExp=3; IntAct=EBI-740781, EBI-14093916;
CC       Q9BT92; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-740781, EBI-6257312;
CC       Q9BT92; Q9H668: STN1; NbExp=3; IntAct=EBI-740781, EBI-746930;
CC       Q9BT92; P14373: TRIM27; NbExp=4; IntAct=EBI-740781, EBI-719493;
CC       Q9BT92; Q9BYV2: TRIM54; NbExp=3; IntAct=EBI-740781, EBI-2130429;
CC       Q9BT92; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-740781, EBI-739895;
CC       Q9BT92; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-740781, EBI-12040603;
CC       Q9BT92; Q9NZV7: ZIM2; NbExp=3; IntAct=EBI-740781, EBI-11962760;
CC       Q9BT92; Q9UDW3: ZMAT5; NbExp=3; IntAct=EBI-740781, EBI-7850213;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:15731013}. Cytoplasm {ECO:0000269|PubMed:18931701}.
CC       Cell membrane {ECO:0000305|PubMed:15731013,
CC       ECO:0000305|PubMed:18931701}. Mitochondrion
CC       {ECO:0000269|PubMed:18931701}. Cell junction, desmosome
CC       {ECO:0000269|PubMed:15731013}.
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in normal urothelial and
CC       breast epithelial cells. Also expressed in the smooth muscle and
CC       endothelial cells. Reduced expression seen in advanced bladder and
CC       breast carcinomas (at protein level). Ubiquitous. Expressed at highest
CC       levels in the heart, skeletal muscle, kidney, liver and testis.
CC       {ECO:0000269|PubMed:18931701}.
CC   -!- PTM: Ubiquitinated. Ubiquitination by the BCR(KCTD17) E3 ubiquitin
CC       ligase complex results in proteasomal degradation, and induces
CC       ciliogenesis. {ECO:0000269|PubMed:25270598}.
CC   -!- SIMILARITY: Belongs to the TCHP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY007230; AAG12971.1; -; mRNA.
DR   EMBL; AK092736; BAC03960.1; -; mRNA.
DR   EMBL; BC004285; AAH04285.1; -; mRNA.
DR   CCDS; CCDS9137.1; -.
DR   RefSeq; NP_001137324.1; NM_001143852.1.
DR   RefSeq; NP_115676.1; NM_032300.4.
DR   RefSeq; XP_011537138.1; XM_011538836.2.
DR   RefSeq; XP_011537139.1; XM_011538837.2.
DR   AlphaFoldDB; Q9BT92; -.
DR   SMR; Q9BT92; -.
DR   BioGRID; 123987; 123.
DR   IntAct; Q9BT92; 83.
DR   MINT; Q9BT92; -.
DR   STRING; 9606.ENSP00000324404; -.
DR   iPTMnet; Q9BT92; -.
DR   PhosphoSitePlus; Q9BT92; -.
DR   BioMuta; TCHP; -.
DR   DMDM; 74733103; -.
DR   EPD; Q9BT92; -.
DR   jPOST; Q9BT92; -.
DR   MassIVE; Q9BT92; -.
DR   MaxQB; Q9BT92; -.
DR   PaxDb; Q9BT92; -.
DR   PeptideAtlas; Q9BT92; -.
DR   PRIDE; Q9BT92; -.
DR   ProteomicsDB; 78961; -.
DR   Antibodypedia; 49415; 159 antibodies from 26 providers.
DR   DNASU; 84260; -.
DR   Ensembl; ENST00000312777.9; ENSP00000324404.5; ENSG00000139437.18.
DR   Ensembl; ENST00000405876.9; ENSP00000384520.4; ENSG00000139437.18.
DR   Ensembl; ENST00000544838.5; ENSP00000440838.1; ENSG00000139437.18.
DR   GeneID; 84260; -.
DR   KEGG; hsa:84260; -.
DR   MANE-Select; ENST00000405876.9; ENSP00000384520.4; NM_001143852.2; NP_001137324.1.
DR   UCSC; uc001tpn.4; human.
DR   CTD; 84260; -.
DR   DisGeNET; 84260; -.
DR   GeneCards; TCHP; -.
DR   HGNC; HGNC:28135; TCHP.
DR   HPA; ENSG00000139437; Low tissue specificity.
DR   MIM; 612654; gene.
DR   neXtProt; NX_Q9BT92; -.
DR   OpenTargets; ENSG00000139437; -.
DR   PharmGKB; PA143485629; -.
DR   VEuPathDB; HostDB:ENSG00000139437; -.
DR   eggNOG; ENOG502QVSH; Eukaryota.
DR   GeneTree; ENSGT01040000240563; -.
DR   HOGENOM; CLU_042533_1_0_1; -.
DR   InParanoid; Q9BT92; -.
DR   OMA; QNSHYFR; -.
DR   OrthoDB; 675049at2759; -.
DR   PhylomeDB; Q9BT92; -.
DR   TreeFam; TF329032; -.
DR   PathwayCommons; Q9BT92; -.
DR   SignaLink; Q9BT92; -.
DR   BioGRID-ORCS; 84260; 17 hits in 1078 CRISPR screens.
DR   ChiTaRS; TCHP; human.
DR   GeneWiki; TCHP; -.
DR   GenomeRNAi; 84260; -.
DR   Pharos; Q9BT92; Tbio.
DR   PRO; PR:Q9BT92; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9BT92; protein.
DR   Bgee; ENSG00000139437; Expressed in sural nerve and 166 other tissues.
DR   ExpressionAtlas; Q9BT92; baseline and differential.
DR   Genevisible; Q9BT92; HS.
DR   GO; GO:0045179; C:apical cortex; IDA:HGNC-UCL.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030057; C:desmosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0045095; C:keratin filament; IDA:HGNC-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0030030; P:cell projection organization; IEA:UniProtKB-KW.
DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:1902018; P:negative regulation of cilium assembly; IMP:UniProtKB.
DR   InterPro; IPR043596; CFAP53/TCHP.
DR   InterPro; IPR026773; TCHP.
DR   InterPro; IPR043597; TPH_dom.
DR   PANTHER; PTHR31183; PTHR31183; 1.
DR   PANTHER; PTHR31183:SF2; PTHR31183:SF2; 1.
DR   Pfam; PF13868; TPH; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Cell junction; Cell membrane; Cilium biogenesis/degradation;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Isopeptide bond; Membrane;
KW   Mitochondrion; Reference proteome; Tumor suppressor; Ubl conjugation.
FT   CHAIN           1..498
FT                   /note="Trichoplein keratin filament-binding protein"
FT                   /id="PRO_0000292609"
FT   REGION          73..498
FT                   /note="Interaction with keratin proteins"
FT                   /evidence="ECO:0000269|PubMed:15731013"
FT   REGION          167..189
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          259..425
FT                   /note="Trichohyalin/plectin homology domain"
FT                   /evidence="ECO:0000269|PubMed:15731013"
FT   REGION          447..498
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          11..39
FT                   /evidence="ECO:0000255"
FT   COILED          66..136
FT                   /evidence="ECO:0000255"
FT   COILED          163..353
FT                   /evidence="ECO:0000255"
FT   COILED          380..479
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        50
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000305|PubMed:25270598"
FT   CROSSLNK        57
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000305|PubMed:25270598"
FT   VARIANT         44
FT                   /note="S -> P (in a gastric carcinoma sample;
FT                   dbSNP:rs202208566)"
FT                   /evidence="ECO:0000269|PubMed:18931701"
FT                   /id="VAR_064056"
FT   VARIANT         93
FT                   /note="E -> K (in a pancreatic carcinoma sample;
FT                   dbSNP:rs200027650)"
FT                   /evidence="ECO:0000269|PubMed:18931701"
FT                   /id="VAR_064057"
FT   VARIANT         127
FT                   /note="K -> R (in dbSNP:rs10774978)"
FT                   /id="VAR_053924"
FT   VARIANT         417
FT                   /note="E -> K (in dbSNP:rs16940680)"
FT                   /id="VAR_053925"
FT   MUTAGEN         50
FT                   /note="K->R: Decreased ubiquitination. Negative effect on
FT                   ubiquitination is higher when associated with R-57."
FT                   /evidence="ECO:0000269|PubMed:25270598"
FT   MUTAGEN         57
FT                   /note="K->R: Decreased ubiquitination. Negative effect on
FT                   ubiquitination is higher when associated with R-50."
FT                   /evidence="ECO:0000269|PubMed:25270598"
FT   CONFLICT        326
FT                   /note="A -> V (in Ref. 3; BAC03960)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   498 AA;  61072 MW;  7D1E8A66C56516F8 CRC64;
     MALPTLPSYW CSQQRLNQQL ARQREQEARL RQQWEQNSRY FRMSDICSSK QAEWSSKTSY
     QRSMHAYQRE KMKEEKRRSL EARREKLRQL MQEEQDLLAR ELEELRLSMN LQERRIREQH
     GKLKSAKEEQ RKLIAEQLLY EHWKKNNPKL REMELDLHQK HVVNSWEMQK EEKKQQEATA
     EQENKRYENE YERARREALE RMKAEEERRQ LEDKLQAEAL LQQMEELKLK EVEATKLKKE
     QENLLKQRWE LERLEEERKQ MEAFRQKAEL GRFLRHQYNA QLSRRTQQIQ EELEADRRIL
     QALLEKEDES QRLHLARREQ VMADVAWMKQ AIEEQLQLER AREAELQMLL REEAKEMWEK
     REAEWARERS ARDRLMSEVL TGRQQQIQEK IEQNRRAQEE SLKHREQLIR NLEEVRELAR
     REKEESEKLK SARKQELEAQ VAERRLQAWE ADQQEEEEEE EARRVEQLSD ALLQQEAETM
     AEQGYRPKPY GHPKIAWN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024